H. Čoupková

Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer

L. Koubková, J. Krejčí, L. Holubec, 2021, AntiCancer Research.

Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study

L. Koubková, J. Krejčí, D. Doležal, 2021, AntiCancer Research.

Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry

L. Koubková, J. Krejčí, L. Havel, 2020, Thoracic cancer.

Uncommon EGFR Mutations in Non-Small Cell Lung Cancer and Their Impact on the Treatment.

T. Kazda, J. Berkovcová, O. Horký, 2019, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

Surgical treatment of an invasive thymoma extending into the right atrium and infiltrating

P. Neužil, Š. Černý, I. Skalský, 2016 .

Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment

L. Koubková, J. Krejčí, D. Doležal, 2021, Anticancer Research.

324 Treatment of brain metastases in patients with non-small-cell lung cancer (NSCLC)

P. Čoupek, H. Čoupková, 1997 .

[Iris metastasis as the first sign of small-cell lung carcinoma with metastatic involvement of the mediastinum].

V. Postránecká, H. Čoupková, T. Jurečka, 2009, Klinicka onkologie.

Vinorelbine and cisplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter Czech study.

V. Kolek, P. Reiterer, P. Prusa, 1995, Acta Medica Austriaca.